Cnc Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.59 M
- Revenue Growth -24.54%
- Profit Growth -16.86%
- Ebitda -25.29%
- Net Worth 88.24%
- Total Assets 9.56%
About Cnc Biotech
Cnc Biotech Private Limited (CBPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 October 2012 and has a history of 12 years and three months. Its registered office is in Bhopal, Madhya Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.59 M.
Deepak Shah, Shruti Shah, and Shardul Shah serve as directors at the Company.
Company Details
-
Location
Bhopal, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U18100MP2012PTC029384
-
Company No.
029384
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Oct 2012
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Cnc Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepak Shah
|
Director | 17-Oct-2012 | Current |
|
Shruti Shah
|
Director | 17-Oct-2012 | Current |
|
Shardul Shah
|
Director | 17-Oct-2012 | Current |
Financial Performance of Cnc Biotech.
Cnc Biotech Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 24.54% decrease. The company also saw a substantial fall in profitability, with a 16.86% decrease in profit. The company's net worth Soared by an impressive increase of 88.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cnc Biotech?
In 2019, Cnc Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
India Waste Management Private LimitedDeepak Shah, Shruti Shah and 1 more are mutual person
-
Bhopal Incinerators Private Limited
Deepak Shah is a mutual person
Charges (Loans)
₹2.59 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.16 Cr
- Union Bank Of India : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Sep 2024 | Hdfc Bank Limited | ₹1.60 M | Open |
| 21 May 2014 | Union Bank Of India | ₹0.99 M | Open |
How Many Employees Work at Cnc Biotech?
Unlock and access historical data on people associated with Cnc Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cnc Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cnc Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.